JAMES KENNEDY: Open Payments
NPI 1780698985 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,203 in 110 payments from 17 companies in 2025. Trend: 2023 $2,042 · 2024 $1,904 · 2025 $2,203
Food & beverage: $2,203
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $375 |
| Neurocrine BioSciences, Inc. | 18 | $352 |
| Vanda Pharmaceuticals Inc. | 9 | $252 |
| Axsome Therapeutics, Inc. | 12 | $203 |
| Teva Pharmaceuticals USA, Inc. | 11 | $202 |
| Alkermes, Inc. | 7 | $151 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $126 |
| Lundbeck LLC | 5 | $94 |
| Corium, LLC | 4 | $91 |
| E.R. Squibb & Sons, L.L.C. | 4 | $77 |
Products named: CAPLYTA, INGREZZA, AUSTEDO XR, REXULTI, Auvelity, HETLIOZ, TRINTELLIX, ARISTADA.
Industry payments across TN — which companies pay providers there.
